Morgan Stanley’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Buy |
|
|||||
|
2025
Q1 | $2.99M | Sell |
|
|||||
|
2024
Q4 | $7.07M | Buy |
|
|||||
|
2024
Q3 | $5.91M | Buy |
|
|||||
|
2024
Q2 | $4.99M | Buy |
|
|||||
|
2024
Q1 | $5.66M | Sell |
|
|||||
|
2023
Q4 | $15.3M | Buy |
|
|||||
|
2023
Q3 | $3.39M | Buy |
|
|||||
|
2023
Q2 | $4.87M | Buy |
|
|||||
|
2023
Q1 | $4.75M | Buy |
|
|||||
|
2022
Q4 | $1.94M | Sell |
|
|||||
|
2022
Q3 | $3.17M | Buy |
|
|||||
|
2022
Q2 | $2.11M | Buy |
|
|||||
|
2022
Q1 | $1.27M | Buy |
|
|||||
|
2021
Q4 | $82K | Sell |
|
|||||
|
2021
Q3 | $875K | Buy |
|